MGMagda Farghali Gabri

Magda Farghali Gabri

*This is an algorithmically generated author record based on publicly available information.

Magda Farghali Gabri has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus

    by Kotb Abbass Metwalley, Hekma Saad Farghaly, Magda Farghali Gabri, Safwat Mohamed Abdel-Aziz, Asmaa Mohamed Ismail, Duaa Mohamed Raafat, Islam Fathy Elnakeeb

    This study was aimed to assess the role of serum midkine (MK) as a biomarker for early detection of diabetic nephropathy (DN) in children with type 1 diabetes mellitus (T1DM) before microalbuminuria emerges. A total of 120 children with T1DM, comprising 60 microalbuminuric patients ( group 1), 60 normoalbuminuric patients ( group 2), and 60 healthy participants as a control group ( group 3) were included in this study. Detailed medical history, clinical examination, and laboratory assessment of high-sensitivity C-reactive protein (hs- CRP) , hemoglobin A1c% (HbA1c%) , lipid profile , urinary albumin creatinine ratio (ACR), serum MK, and estimated glomerular filtration rate based on serum creatinine (eGFR-Cr) were performed in the three studied group. Our study revealed significantly higher serum MK in both diabetic groups compared to controls (p < 0.001). Additionally, patients with microalbuminuria had higher serum MK concentrations than those with normoalbuminuria (p<0.001). The normoalbuminuric group had highly significantly elevated serum MK compared with the control group (p < 0.001). Receiver operating characteristic (ROC) curve analysis revealed that MK cutoff value of 1512 pg/ml was able to predict microalbuminuria with a sensitivity of 96% and specificity of 92%. Stepwise regression analysis revealed that HbA1c %, hs- CRP, and urinary ACR were independently related to MK levels (p < 0.001 for each). The results of this study suggest that serum MK is a useful, novel, practical marker for the evaluation of renal involvement in children with T1DM, especially in normoalbuminuric children.


  • Open Access

    Overview of Newborn Hearing Screening by transient otoacoustic emissions in Aswan, Egypt: A Hospital-Based preliminary Study

    by Mohamed M Elmoursy, Ashraf Meabed, Hager S Nagdy, Hanan M Aly, Edrees Zaki, Magda F Gabri

    Objectives: One of the most significant risk groups for hearing loss is neonates who spend time in the neonatal intensive care unit (NICU). This study aimed to estimate the prevalence of hearing loss in all neonates admitted to our hospital NICU and evaluate their risk factors. It is a prospective cross-sectional study conducted on all neonates admitted to our hospital in one year. Patients and methods: All Neonates were subjected to history, clinical, Otoscopic examination, and Oto-acoustic emissions test. Neonates with congenital ear anomalies or ear problems that interfere with the screening test were excluded. Results: 90.6% of cases passed the test, and 9.4% had a Refer result in the initial screening. A repeated test for the referral cases showed 6.7% passed and 2.7% had hearing affection (2% bilateral and 0.7 % unilateral). Conclusions: The prevalence of hearing loss was 2.7%, 2 % had bilateral hearing affection, and 0.7 % had unilateral hearing affection. There was a significant correlation between exposures to certain risk factors among the affected neonates; all cases remained more than 5 days in NICU with history of exposure to ototoxic drugs, especially gentamycin, furosemide, vancomycin, and amikacin.